Renal Failure Clinical Trial
Official title:
A Prospective Randomized Controlled Trial of Local Anaesthetic Percutaneous Insertion Versus General Anaesthetic Open Surgical Placement of Continuous Peritoneal Dialysis Catheters in a University Teaching Hospital
NCT number | NCT01023191 |
Other study ID # | Access 3 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | February 2015 |
Est. completion date | September 2018 |
Verified date | July 2019 |
Source | Hull and East Yorkshire Hospitals NHS Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Healthy kidneys clean your blood by removing excess fluid, minerals, and wastes. When your
kidneys fail, harmful wastes build up in your body and your body may retain excess fluid.
When this happens, you need treatment to replace the work of your failed kidneys. This may be
with a dialysis machine using haemodialysis or with fluid in the abdomen or peritoneal
dialysis.
In peritoneal dialysis, a tube called a catheter is put in the abdomen wall and used to fill
your abdomen with a cleansing liquid called dialysis solution. The walls of your abdominal
cavity are lined with a membrane called the peritoneum, which allows waste products and extra
fluid to pass from your blood into the dialysis solution. These wastes and fluid are removed
from the body when the dialysis fluid is drained and replaced with a fresh solution.
The tubes or catheters used to exchange the fluid are currently positioned using a general
anaesthetic (with the patient awake) and an operation with a cut under the belly button.
Newer techniques using local anaesthetic (with the patient awake and the area numbed) and
requiring only a small cut in the skin have been used. No one has ever directly compared the
two techniques.
The investigators aim is to perform a direct comparison between the two techniques to look at
the complications and time required for surgery and length of hospital stay required. The
investigators will also look at the patients satisfaction and pain scores with each technique
to help gather evidence as to which is likely to be the best technique to use from now on.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | September 2018 |
Est. primary completion date | July 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Potential participating patients will be identified by referral to the vascular surgery
department for insertion of CAPD catheter for peritoneal access. Specific inclusion criteria necessary for invitation to study participation; - Patients referred to vascular consultants for CAPD catheter insertion General inclusion criteria: - Ability to give informed written consent Specific exclusion criteria: - Previous abdominal surgery via midline incision - Unfit for general anaesthetic - Aged under 18 at time of referral General exclusion criteria: - Inability to give informed written consent - Inability to attend follow up appointments Withdrawal criteria: - Patient request - Patient non compliance with study protocol |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Hull Royal Infirmary | Hull | East Yorkshire |
Lead Sponsor | Collaborator |
---|---|
Hull and East Yorkshire Hospitals NHS Trust | University of Hull |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Catheter survival | Time to catheter removal for any reason.recorded as percentage inn situ at 6, 12,18,etc months post procedure. | Ongoing (recorded at 6 month intervals) | |
Secondary | Peri operative complications (bleeding, bowel injury) | All complications occuring at time of procedure and in 24 hours immediately post procedure. | 24 hrs post procedure | |
Secondary | Mechanical Complication (drainage failure, displacement, fluid leak) | All mechanical complications recorded during follow up period. Note of timing of complications will be made in results. Early = within 30 days, late = beyond 30 days | ongoing (reported at 30 days and monthly thereafter) | |
Secondary | Infective complications (exit site, tunnel, peritonitis) | All infective complications recorded during follow up period. Note of timing of complications will be made in results. Early = within 30 days, late = beyond 30 days | ongoing (reported at 30 days and monthly thereafter) | |
Secondary | Operative time | Time to complete procedure from start to finish. | Average of 2 hours post procedure | |
Secondary | Technical Success of placement | Assessment of whether a working and useable catheter is in situ at the end of the procedure. | Average of 2 hours post procedure | |
Secondary | Length of admission | Length of admission post procedure according to strict discharge criteria. | Average of 48 hours post procedure | |
Secondary | Patient reported pain post procedure | Analgesia and daily pain scoring diaries will be issued to patients post procedure. These will record patient reported pain at 24 hour intervals to 5 days as well as analgesia taken during the same period. | 24 hour intervals to 5 days post procedure | |
Secondary | Quality of life assessment by questionnaire | Within 24 hours prior to procedure, and again at both 5 days and 3 months post procedure | ||
Secondary | Estimated cost of care episode | Overall estimated cost of admission, procedure, ongoing care of catheter and management of complications arising from catheter or procedure will be calculated. | 3 months post procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02763410 -
Impact of the Composition of Packed Red Blood Cell Supernatant on Renal Dysfunction and Posttransfusion Immunomodulation
|
||
Active, not recruiting |
NCT03183245 -
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
|
Phase 3 | |
Completed |
NCT04084301 -
Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury
|
N/A | |
Completed |
NCT03292029 -
Pilot Medical Evaluation of the T50 Test
|
N/A | |
Suspended |
NCT04589065 -
SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)
|
N/A | |
Completed |
NCT03806998 -
Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure
|
Phase 3 | |
Active, not recruiting |
NCT03672110 -
Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
|
Phase 3 | |
Completed |
NCT02325726 -
RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery.
|
N/A | |
Completed |
NCT02116270 -
Accelerated Immunosenescence and Chronic Kidney Disease
|
N/A | |
Completed |
NCT01859273 -
Adherence Enhancement for Renal Transplant Patients
|
N/A | |
Completed |
NCT01388270 -
Effect of a Pre Heparin Coated Dialysis Filter on Coagulation During Hemodialysis
|
Phase 4 | |
Completed |
NCT00966615 -
The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition
|
Phase 4 | |
Completed |
NCT01187953 -
Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacroâ„¢ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx
|
Phase 3 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01008631 -
The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy Volunteers
|
N/A | |
Completed |
NCT00765661 -
Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients
|
Phase 2 | |
Completed |
NCT00737672 -
GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis
|
Phase 3 | |
Completed |
NCT00808691 -
Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
|
N/A | |
Recruiting |
NCT00470769 -
The Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFR
|
N/A | |
Terminated |
NCT00338455 -
Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC
|
Phase 2 |